SG/CALL/ECKERT & ZIEGLER STRAHLEN/52/0.1/20.12.24

SG/CALL/ECKERT & ZIEGLER STRAHLEN/52/0.1/20.12.24 Stock

DE000SU9XJF6

Real-time Boerse Frankfurt Warrants 05:05:56 2024-06-13 EDT
0.43 ^EUR	-4.44%

Current month	+21.62%
1 month	+95.65%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ECKERT & ZIEGLER SE

Chart SG/CALL/ECKERT & ZIEGLER STRAHLEN/52/0.1/20.12.24

Latest news about ECKERT & ZIEGLER SE

Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-31	EQ
Eckert & Ziegler Hosts Second Radionuclide Theranostics Forum in Boston, MA	05-31	EQ
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-30	EQ
Eckert & Ziegler receives “Best Managed Companies Award”	05-24	EQ

More news

Quotes 5-day view

Date	Price	Change
24-06-13	0.43	-4.44%
24-06-12	0.45	+2.27%
24-06-11	0.44	-4.35%
24-06-10	0.46	-2.13%
24-06-07	0.47	-2.08%

Real-time Boerse Frankfurt Warrants

Last update June 13, 2024 at 05:05 am

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	ECKERT & ZIEGLER SE
Issuer	Société Générale
WKN	SU9XJF
ISIN	DE000SU9XJF6
Date issued	2024-02-27
Strike	52 €
Maturity	2024-12-20 (191 Days)
Parity	10 : 1
Emission price	0.32 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	0.54 €
Lowest since issue	0.097 €
Delta	0.46x
Omega	4.950
Premium	19.89x
Gearing	10.8x
Moneyness	0.9038
Difference Strike	5.27 €
Difference Strike %	+10.13%
Spread	0.01 €
Spread %	2.27%
Theoretical value	0.4350
Implied Volatility	43.69 %
Total Loss Probability	66.11 %
Intrinsic value	0.000000
Present value	0.4350
Break even	56.35 €
Theta	-0.01x
Vega	0.01x
Rho	0.01x

Company Profile

Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Sector

More about the company